Stability Solutions, LLC v. Medacta USA, Inc.

District Court, N.D. California·Decided January 20, 2023·No. 3:22-cv-07412·Unknown

Opinion

San Francisco Division STABILITY SOLUTIONS, LLC, Case No. 22-cv-07412-LB

Plaintiff, ORDER GRANTING MOTION TO v. TRANSFER VENUE

MEDACTA USA, INC., Re: ECF No. 5 Defendant. This is a contract dispute between a medical-device sales agent and a medical-device manufacturer. The plaintiff and its sole owner, Ash Shaalan, entered into an independent-sales- agent agreement with the defendant manufacturer Medacta in April 2021 for the plaintiff to sell the defendant’s joint-replacement implants in the Bay Area for two years. The agreement had sales-volume requirements and provided that if the plaintiff did not meet them, the defendant could terminate the agreement if it first gave the plaintiff notice and an opportunity to cure the default. But in July 2022, the defendant allegedly terminated the agreement without notice or an opportunity to cure. The plaintiff sued for breach of contract, among other claims.1 1 Compl. – ECF No. 1-1 at 3–16. Citations refer to material in the Electronic Case File (ECF); pinpoint Invoking the agreement’s forum-selection clause, the defendant moved to dismiss for improper venue under Federal Rule of Civil Procedure 12(b)(3) and alternatively moved to transfer venue to the Middle District of Tennessee under 28 U.S.C. § 1404(a).2 The plaintiff contends mainly that the forum-selection clause, especially in combination with the Delaware choice-of-law clause, is unenforceable because it waives the plaintiff’s rights under California’s Independent Wholesale Sales Representative Act, Cal. Civ. Code § 1738.13(e).3 The court denies the motion to dismiss because venue is proper in this removed case. But the court grants the motion to transfer venue because the forum-selection clause is enforceable and the plaintiff has not carried its burden to show that transfer is inappropriate under § 1404(a). The plaintiff is a Wyoming company that “sell[s] implantable medical devices and instrumentation to orthopedic surgeons.” The defendant is a Delaware company that “manufactur[es] implantable medical devices and instruments for joint replacements.” Both parties do business in California.4 Starting in January 2021, the defendant recruited the plaintiff to help expand the defendant’s customer base in the Bay Area.5 In April 2021, the parties entered into their independent sales agent agreement. It allegedly was partly in writing, partly oral, and partly implied by conduct.6 It appointed the plaintiff as the defendant’s “independent outside sales representative, tasked with selling and marketing [the defendant’s] medical devices and instrumentation . . . to hospitals, medical centers, and physicians in California.”7

2 Mot. – ECF No. 5. 3 Opp’n – ECF No. 12. 4 Compl. – ECF No. 1-1 at 4 (¶¶ 1–4), 5 (¶¶ 7–8). 5 Id. at 5 (¶ 9). 6 Id. (¶ 10); Agreement, Ex. 1 to Hancock Decl. – ECF No. 17-1 at 4–22. The written agreement required the plaintiff to meet a “minimum sales volume” of $2 million in the first year. It provided that if the plaintiff did not meet this target or seventy-five percent of the applicable volume for two consecutive quarters, the defendant could limit the plaintiff’s sales territories or terminate the agreement “upon notice and an opportunity to cure.”8 The cure process had four steps: the defendant provides notice; the plaintiff submits a written improvement plan; the defendant accepts, modifies, or rejects the plan; and the defendant gives the plaintiff an opportunity to cure the default.9 The agreement also had a forum-selection clause (under which all actions “arising out of or relating to” the agreement must be brought in the United States District Court for the Middle District of Tennessee) and a Delaware choice-of-law clause.10 The plaintiff alleges that when the agreement was entered into, the defendant’s Area Director and Vice President of Sales “assured [Mr.] Shalaan that the Minimum Sales Volume number was only a ‘soft goal’” and that the plaintiff would not actually be required to achieve the minimum. They “emphasized that the Minimum Sales Volume number was not realistic” for the first year and that “any growth” Mr. Shalaan could achieve would be sufficient, because the defendant “had failed to penetrate the Bay Area market for years.” And they acknowledged that the plaintiff would need “significant support” to successfully recruit customers.11 From April 2021 until December 2021, the plaintiff hired three independent-contractor sales representatives and “steadily increased the amount of [the defendant’s] sales and the number of surgeons using [the defendant’s] products in the Bay Area.” During this time, the defendant provided the plaintiff with support, such as by coordinating mobile labs for surgeons and participating in sales calls.12 But in December 2021, after replacing its Area Director, the defendant allegedly stopped providing support and started ignoring Mr. Shalaan’s calls and emails. Without

Free access — add to your briefcase to read the full text and ask questions with AI

Stability Solutions, LLC v. Medacta USA, Inc., (N.D. Cal. 2023).

Stability Solutions, LLC v. Medacta USA, Inc. (Stability Solutions, LLC v. Medacta USA, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Jennings v. Carson
8 U.S. 2 (Supreme Court, 1807)
Norwood v. Kirkpatrick
349 U.S. 29 (Supreme Court, 1955)
The Bremen v. Zapata Off-Shore Co.
407 U.S. 1 (Supreme Court, 1972)
Piper Aircraft Co. v. Reyno
454 U.S. 235 (Supreme Court, 1982)
United States v. Steven M. Self
2 F.3d 1071 (Tenth Circuit, 1993)
Simula, Inc. v. Autoliv, Inc.
175 F.3d 716 (Ninth Circuit, 1999)
Robin Orr v. Bank of America, Nt & Sa
285 F.3d 764 (Ninth Circuit, 2002)
Murphy v. Schneider National, Inc.
362 F.3d 1133 (Ninth Circuit, 2004)
Doe 1 v. AOL LLC
552 F.3d 1077 (Ninth Circuit, 2009)
Lowden v. T-MOBILE USA, INC.
512 F.3d 1213 (Ninth Circuit, 2008)
America Online, Inc. v. Superior Court
108 Cal. Rptr. 2d 699 (California Court of Appeal, 2001)
Jones v. GNC Franchising, Inc.
211 F.3d 495 (Ninth Circuit, 2000)